Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal for Immunotherapy of Cancer|April 17, 2025
Shp-1 regulates the activity of low-affinity T cells specific to endogenous self-antigen during melanoma tumor growth and drives resistance to immune checkpoint inhibitionJoseph G Matous, Jeremy P Snook, Nico A Contreras, et al.Frontiers in Immunology|December 7, 2017
Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV EpitopeDavid K Cole, Anna Fuller, Garry Dolton, et al.Science (New York, N.Y.)|September 15, 2018
Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cellsDaniel DiToro, Colleen J Winstead, Duy Pham, et al.Molecular Cell|February 4, 2019
Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen RecognitionPeng Wu, Tongtong Zhang, Baoyu Liu, et al.Science (New York, N.Y.)|June 4, 2021
Canonical T cell receptor docking on peptide-MHC is essential for T cell signalingPirooz Zareie, Christopher Szeto, Carine Farenc, et al.Cell|July 28, 2018
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC BindingLeah V Sibener, Ricardo A Fernandes, Elizabeth M Kolawole, et al.Science (New York, N.Y.)|March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineeringXiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.Cancer Immunology, Immunotherapy : CII|December 22, 2017
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cellsTamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.Cancer Immunology, Immunotherapy : CII|October 21, 2017
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cellsTamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.Pageof 9